Literature DB >> 8460917

In vitro activities of ceftriaxone and fusidic acid against 13 isolates of Coxiella burnetii, determined using the shell vial assay.

H Torres1, D Raoult.   

Abstract

The susceptibilities of 13 isolates of Coxiella burnetii to fusidic acid and ceftriaxone were determined by use of the recently described shell vial assay (D. Raoult, H. Torres, and M. Drancourt, Antimicrob. Agents Chemother, 35:2070-2077, 1991). At a concentration of 4 micrograms/ml, ceftriaxone was bacteriostatic for four isolates and slowed the multiplication of the other nine. Fusidic acid at a concentration of 2 micrograms/ml was bacteriostatic for six isolates and slowed the multiplication of three others. These results show that these compounds could be effective in the phagolysosome of C. burnetii-infected cells.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8460917      PMCID： PMC187697          DOI： 10.1128/AAC.37.3.491

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  24 in total

1.  In vitro activities of lomefloxacin, tetracycline, penicillin, spectinomycin, and ceftriaxone against Neisseria gonorrhoeae and Chlamydia trachomatis.

Authors:  H Talbot; B Romanowski
Journal:  Antimicrob Agents Chemother       Date:  1989-12       Impact factor: 5.191

2.  Antibiotic susceptibilities of two Coxiella burnetii isolates implicated in distinct clinical syndromes.

Authors:  M R Yeaman; M J Roman; O G Baca
Journal:  Antimicrob Agents Chemother       Date:  1989-07       Impact factor: 5.191

3.  Osteoarticular infection due to Coxiella burnetii.

Authors:  D Raoult; G Bollini; H Gallais
Journal:  J Infect Dis       Date:  1989-06       Impact factor: 5.226

4.  Q fever endocarditis in the south of France.

Authors:  D Raoult; J Etienne; P Massip; S Iaocono; M A Prince; P Beaurain; S Benichou; J C Auvergnat; P Mathieu; P Bachet
Journal:  J Infect Dis       Date:  1987-03       Impact factor: 5.226

5.  Coxiella burnetii infection of a vascular prosthesis.

Authors:  D Raoult; P Piquet; H Gallais; C de Micco; M Drancourt; P Casanova
Journal:  N Engl J Med       Date:  1986-11-20       Impact factor: 91.245

Review 6.  The pharmacokinetics of fusidic acid.

Authors:  D S Reeves
Journal:  J Antimicrob Chemother       Date:  1987-10       Impact factor: 5.790

Review 7.  The treatment of staphylococcal endocarditis.

Authors:  S J Eykyn
Journal:  J Antimicrob Chemother       Date:  1987-09       Impact factor: 5.790

8.  Concentrations of fusidic acid, cloxacillin, and cefamandole in sera and atrial appendages of patients undergoing cardiac surgery.

Authors:  M G Bergeron; D Desaulniers; C Lessard; M Lemieux; J P Després; J Métras; G Raymond; G Brochu
Journal:  Antimicrob Agents Chemother       Date:  1985-06       Impact factor: 5.191

9.  Autoradiographic evidence for penetration of 3H-ceftriaxone (Rocephin) into cells of spleen, liver and kidney of mice.

Authors:  H Kuhn; P Angehrn; L Havas
Journal:  Chemotherapy       Date:  1986       Impact factor: 2.544

10.  In vitro susceptibility of Brucella melitensis to new cephalosporins crossing the blood-brain barrier.

Authors:  E Palenque; J R Otero; A R Noriega
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191
View more
  6 in total

Review 1.  Current and past strategies for bacterial culture in clinical microbiology.

Authors:  Jean-Christophe Lagier; Sophie Edouard; Isabelle Pagnier; Oleg Mediannikov; Michel Drancourt; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

Review 2.  Treatment of Q fever.

Authors:  D Raoult
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

3.  Q fever pneumonia: virulence of Coxiella burnetii pathovars in a murine model of aerosol infection.

Authors:  Andreas Stein; Céline Louveau; Hubert Lepidi; Fanny Ricci; Pascal Baylac; Bernard Davoust; Didier Raoult
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

4.  In vitro susceptibility of Coxiella burnetii to linezolid in comparison with its susceptibilities to quinolones, doxycycline, and clarithromycin.

Authors:  A Gikas; I Spyridaki; E Scoulica; A Psaroulaki; Y Tselentis
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

5.  In vitro susceptibility of Coxiella burnetii to trovafloxacin in comparison with susceptibilities to pefloxacin, ciprofloxacin, ofloxacin, doxycycline, and clarithromycin.

Authors:  A Gikas; I Spyridaki; A Psaroulaki; D Kofterithis; Y Tselentis
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191

6.  Q fever in Thailand.

Authors:  Yupin Suputtamongkol; Jean-Marc Rolain; Kitti Losuwanaruk; Kanigar Niwatayakul; Chuanpit Suttinont; Wirongrong Chierakul; Kriangsak Pimda; Didier Raoult
Journal:  Emerg Infect Dis       Date:  2003-09       Impact factor: 6.883
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.